3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
2
Tobacco Use Disorder
1
Stress Disorders, Post-Traumatic
1
Smoking Cessation
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Digestive System Abnormalities
1
Depression
1
Anxiety Disorders
1
Acquired Immunodeficiency Syndrome
1
Interventions
pomalidomide
2
liposomal doxorubicin
2
plerixafor
1
abemaciclib
1
Watchful Waiting
1
Vincristine
1
Transurethral Resection of Prostate
1
Self Care
1
Rituximab
1
Proctoscopy
1
Prednisone
1
Paclitaxel
1
Nivolumab
1
Maraviroc
1
Human Papillomavirus Recombinant Vaccine nonavalent
1
Focus Groups
1
Fluorouracil
1
Filgrastim
1
Etoposide
1
Doxorubicin
1
Cyclophosphamide
1
Colposcopy
1
Blood Specimen Collection
1
Benzethonium
1
Anti-HIV Agents
1
Amyloid
1
Acetic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Acquired Immunodeficiency Syndrome
×
Amyloid
×
1 year
×
Clear all
NCT06883097
2025-12-17
QMH
Wake Forest University Health Sciences
Phase NA
Recruiting
314 enrolled